Formestane topical - Eucodis

Drug Profile

Formestane topical - Eucodis

Alternative Names: Formestane topical cream; SaveCream

Latest Information Update: 22 Oct 2013

Price : $50

At a glance

  • Originator Medical Discoveries
  • Developer Eucodis
  • Class Androstenes; Antineoplastics; Ketosteroids; Small molecules
  • Mechanism of Action Aromatase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Breast cancer

Most Recent Events

  • 22 Oct 2013 Discontinued - Clinical-Phase-Unknown for Breast cancer in Europe prior to October 2013 (Topical)
  • 22 Oct 2013 Discontinued - Clinical-Phase-Unknown for Breast cancer in USA prior to October 2013 (Topical)
  • 11 Aug 2006 Clinical trials in Breast cancer in Europe (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top